Article
A new look at the role of p53 in leukemia cell sensitivity to chemotherapy.
Leukemia - 1 Nov 1997
Trepel M, Scheding S, Groscurth P, Horny H P, Malipiero U, Brugger W, Dichgans J, Weller M
Abstract excerpt
A gene encoding the p53 val135 mutant, which assumes mutant conformation at 38.5 degrees C and wild-type conformation at 32.5 degrees C, was introduced into p53-deficient K562 myeloid leukemia cells. Forced expression of wild-type, but not mutant, p53 resulted in growth arrest, accumulation of p21 and Bax proteins, and delayed cell death. Wild-type p53 enhanced the cytotoxic effects of some drugs and attenuated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
